PCN3 EPIDEMIOLOGICAL, CLINICAL AND HUMANISTIC BURDEN AMONG ALK+ NON-SMALL CELL LUNG CANCER (ALK+NSCLC) PATIENTS TREATED WITH FIRST-LINE ALK INHIBITORS: RESULTS OF A SYSTEMATIC LITERATURE REVIEW (SLR)
Pan, X., Kwon, C.S., Garib, S.A., Forsythe, A., Lin, H.M.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.127
Date:
May, 2019
File:
PDF, 380 KB
2019
File converter
More search results
More benefits 
